348 related articles for article (PubMed ID: 32956996)
1. Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.
Kara G; Parlar A; Cakmak MC; Cokol M; Denkbas EB; Bakan F
Colloids Surf B Biointerfaces; 2020 Dec; 196():111340. PubMed ID: 32956996
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.
Mattheolabakis G; Ling D; Ahmad G; Amiji M
Pharm Res; 2016 Dec; 33(12):2943-2953. PubMed ID: 27528390
[TBL] [Abstract][Full Text] [Related]
3. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
4. Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases.
Kedinger V; Meulle A; Zounib O; Bonnet ME; Gossart JB; Benoit E; Messmer M; Shankaranarayanan P; Behr JP; Erbacher P; Bolcato-Bellemin AL
BMC Cancer; 2013 Jul; 13():338. PubMed ID: 23835136
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of amino acid-functionalized calcium phosphate nanoparticles for siRNA delivery.
Bakan F; Kara G; Cokol Cakmak M; Cokol M; Denkbas EB
Colloids Surf B Biointerfaces; 2017 Oct; 158():175-181. PubMed ID: 28689100
[TBL] [Abstract][Full Text] [Related]
6. Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs.
Li J; Wang Y; Xue S; Sun J; Zhang W; Hu P; Ji L; Mao Z
Int J Nanomedicine; 2016; 11():4609-4624. PubMed ID: 27695321
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells.
Akbaba H; Erel-Akbaba G; Kotmakçı M; Başpınar Y
Pharm Res; 2020 Aug; 37(8):165. PubMed ID: 32761250
[TBL] [Abstract][Full Text] [Related]
8. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
[TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.
Qiu C; Wei W; Sun J; Zhang HT; Ding JS; Wang JC; Zhang Q
Nanoscale; 2016 Jul; 8(26):13033-44. PubMed ID: 27314204
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect
Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN
Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
[TBL] [Abstract][Full Text] [Related]
12. GABA
Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
[TBL] [Abstract][Full Text] [Related]
13. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
14. Enhancing anti-melanoma outcomes in mice using novel chitooligosaccharide nanoparticles loaded with therapeutic survivin-targeted siRNA.
Liu X; Chen L; Zhang Y; Xin X; Qi L; Jin M; Guan Y; Gao Z; Huang W
Eur J Pharm Sci; 2021 Mar; 158():105641. PubMed ID: 33220463
[TBL] [Abstract][Full Text] [Related]
15. Reduction sensitive nanocarriers mPEG-g-γ-PGA/SSBPEI@siRNA for effective targeted delivery of survivin siRNA against NSCLC.
Chen L; Wang S; Liu Q; Zhang Z; Lin S; Zheng Q; Cheng M; Li Y; Cheng C
Colloids Surf B Biointerfaces; 2020 Sep; 193():111105. PubMed ID: 32417465
[TBL] [Abstract][Full Text] [Related]
16. F127/Calcium phosphate hybrid nanoparticles: a promising vector for improving siRNA delivery and gene silencing.
Qin L; Sun Y; Liu P; Wang Q; Han B; Duan Y
J Biomater Sci Polym Ed; 2013; 24(15):1757-66. PubMed ID: 23746331
[TBL] [Abstract][Full Text] [Related]
17. The pH-triggered polyglutamate brush co-delivery of MDR1 and survivin-targeting siRNAs efficiently overcomes multi-drug resistance of NSCLC.
Wang Z; Liang Y; Liu Y; Xia H; Liu J; Jin X; Li Z
Drug Dev Ind Pharm; 2020 Nov; 46(11):1862-1872. PubMed ID: 32924641
[TBL] [Abstract][Full Text] [Related]
18. Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer.
Ma S; Li X; Ran M; Ji M; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X
Int J Pharm; 2021 May; 601():120577. PubMed ID: 33839227
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro.
Wu Z; Xu XL; Zhang JZ; Mao XH; Xie MW; Cheng ZL; Lu LJ; Duan XH; Zhang LM; Shen J
Nanomaterials (Basel); 2017 May; 7(5):. PubMed ID: 28492491
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
